Pharma Journalist -

Novo Nordisk has confirmed submitting an unsolicited proposal to acquire U.S.-based Metsera, Inc., a biotechnology company developing early- and mid-stage incretin and non-incretin…
Read More...

Swiss biopharmaceutical company Debiopharm has entered into a strategic research collaboration with South Korea–based biotech firm NetTargets to accelerate the discovery of novel,…
Read More...

Seres Therapeutics, Inc. announced that CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) has awarded the company up to $3.6 million in additional…
Read More...

The U.S. Food and Drug Administration (FDA) has unveiled a new draft guidance aimed at making the development of biosimilar medicines—lower-cost alternatives to expensive biologic…
Read More...

London, UK – 30 October 2025 – SAE Media Group has officially unveiled the agenda for the 7th Annual AI in Drug Discovery conference, taking place 9–10 March 2026 at the Hilton London…
Read More...

Alexion, AstraZeneca Rare Disease, announced that the European Commission has approved Koselugo (selumetinib) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN)…
Read More...

Kazia Therapeutics Limited announced plans to hold a follow-up Type C meeting with the U.S. Food and Drug Administration (FDA) to discuss new overall survival (OS) findings from…
Read More...

Novartis announced that it has successfully completed the acquisition of Tourmaline Bio, Inc., making the biotechnology company an indirect wholly owned subsidiary of Novartis.…
Read More...

Guardant Health, a leader in precision oncology, has announced a strategic partnership with Zephyr AI, a precision medicine company specializing in artificial intelligence, to…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has expanded the approval of WINREVAIR™ (sotatercept-csrk) for the…
Read More...